Skip to Main Content

Select market
Contact us
Symbols Glossary

Go to startpage

Go to startpage Menu

News
- News
  Collaboration is key to our success. Explore what we’re saying, what we’re sharing and what we’re thinking.
  Overview
  Mölnlycke News
  
  Media and press
  
  Events
Careers
- Careers
  See available jobs
  Overview
  Mölnlycke mindset
  
  Working at Mölnlycke
  
  Available jobs
About us
- About us
  Mölnlycke is a world leading medical solutions company, with the purpose to advance performance in healthcare across the world.
  Overview
  Our history
  
  Our governance
  
  Sustainability
  
  This is Mölnlycke
  
  Grants and research
  
  Business Areas
  
  Strategy
Our knowledge
Products and solutions
- Product ranges
  
  Antiseptics
  
  BARRIER surgical drapes
  
  BARRIER staff clothing
  
  Biogel gloves
  
  Mepilex dressings
  
  ProcedurePak trays
  
  Mölnlycke surgical instruments
  
  Wound management
  
  Oxygen Therapy and Wound Irrigation
  
  Temperature management
  In focus: Wound types
  
  Burns
  
  Epidermolysis bullosa
  
  Infected wound
  
  Pressure Ulcers
  
  Incision care solutions
  
  Skin Tears
  
  Surgical wound healing HUB
  
  Venous leg ulcer
  
  Wound irrigation
  Solutions
  
  Mölnlycke Portal
  
  Case finder
  
  Mölnlycke Wound Support
  
  My Mölnlycke
  
  Wound Care Value
  
  Certificates critical environment
  The Exufiber Effect: The difference you can see. The difference they can feel.
  
  Highly exuding wounds are challenging to treat. That is why we are providing a wound healing solution that clinicians want to see and that patients can feel.
  Learn more
Education
- Education
  Overview
  Wound areas
  
  Webinars
  
  Podcasts
  
  E-learnings
  
  Evidence and Insights

Select market
Contact us
Symbols Glossary

I'm looking for

Updates from around the Mölnlycke world
Current: Mölnlycke publishes 2020 Annual Report

Annual Report

Mölnlycke publishes 2020 Annual Report

April 7, 2021

The 2020 report shows the company achieved strong organic sales growth, partly through supplying personal protective equipment (PPE) during the COVID-19 pandemic.

The company also welcomed its new CEO Zlatko Rihter during the year and launched its innovative new negative pressure wound therapy (NPWT) solution Advance® Solo.

Performance highlights include:

· Organic sales growth of 18%

· Total net sales of 1,793 million EUR

· EBITDA of 536 million EUR

· 300 million extra items of PPE supplied

· Good progress towards sustainability targets

Download the 2020 Mölnlycke Annual report here.

Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes.

Get to know us

About us
Products and solutions
Our knowledge
External links
Contact us

Get the details

Regulatory support
Products - Instructions for use
Media and press
Privacy Center
Terms of use
Cookie policy
Site map

Attention: The information provided in this site/page is intended solely for indicative purpose. While we have taken any precautions to ensure that the content of this site/page is both current and accurate, errors can occur. In all cases you should consult with the IFU accompanying the product before using the product.

The Mölnlycke, Alldress, Avance, BARRIER, Biogel, Biogel Eclipse, Biogel Orthropro, Biogel PI Pro-Fit, Biogel Sensor, Deep Defense, Easywarm, Elset, Epaderm, Exufiber, Granulox, Granudacyn, Hydrolock, EZ Derm, Hacdil-S, Hibi, Hibicet, Hibiclens, Hibidil, Hibiscrub, Indicator, Mefix, Melgisorb, Mextra, Mepiform, Mepilex, Mepiseal, Mepitac, Mepitel, Mepore, Mesalt, Mesoft, Mesorb, Mestopore, Neoderm, Normlgel, PI Indicator, PI UltraTouch, ProcedurePak, Reveal, Safetac, Setopress, Skinsense, Tubifast, Tubifast 2-way stretch and Tubigrip trademarks, names and logos are registered globally to one or more of the Mölnlycke Health Care group of companies.

Product ranges

In focus: Wound types

Solutions